Hossein Rafimanesh; Mahshid Ghoncheh; Hamid Salehinia; Abdollah Mohammadian Hafashjani
Volume 23, Issue 2 , March and April 2016, , Pages 320-327
Abstract
Background & Objectives: Prostate cancer is the most commonly diagnosed cancer in men. This type of cancer is the second leading cause of death and is of the highest prevalence in men. Therefore, having a general picture of the characteristics and changes of the cancer epidemiology is essential for ...
Read More
Background & Objectives: Prostate cancer is the most commonly diagnosed cancer in men. This type of cancer is the second leading cause of death and is of the highest prevalence in men. Therefore, having a general picture of the characteristics and changes of the cancer epidemiology is essential for this type of cancer. The aim of this study was to investigate the epidemiology of prostate cancer and its incidence trends in Iran. Methods: This cross - sectional study conducted on date extracted from cancer registry system in Iran during 2003 to 2009. After separation of the data for prostate cancer, number of cases, incidence, and standardized incidence were studied, and the epidemiological characteristics of the disease during the studied period were presented. Results: Incidence of prostate cancer in Iran has an increasing trend, so that the number of cases recorded in 2003 and 2009 are 1548 and 3856 cases, respectively. The lowest age-standardized incidence rate (ASR) observed in 2003 whit 5.4 and the highest ASR observed in 2009 whit 12. Among provinces, Tehran has the highest cases of prostate cancer and Sistan and Baluchistan province has the lowest cases. The highest incidence rate reported in the age group above 50 years. Conclusion: Prostate cancer is a disease of older men that its incidence is increasing in Iran. Due to the changing in lifestyle of the people and the aging of the population, planning to conduct epidemiological and etiological studies about this cancer and early detection of disease by using screening test seems necessary.
Fatemeh Kohi; Hamid Salehinia; Abdollah Mohammadian-Hafshejani
Volume 22, Issue 4 , September and October 2015, , Pages 630-638
Abstract
Background & Objectives: Cardiovascular disease is the main cause of death and disability worldwide and is known as one of the major threats to human health. Therefore, this study was aimed to investigate the changes in mortality from cardiovascular disease in Iran. Materials and Methods: This cross-sectional ...
Read More
Background & Objectives: Cardiovascular disease is the main cause of death and disability worldwide and is known as one of the major threats to human health. Therefore, this study was aimed to investigate the changes in mortality from cardiovascular disease in Iran. Materials and Methods: This cross-sectional study was done using analysis of data published in the mortality profile in Iran (29 Provinces) over the years 2006 to 2010. The trend of mortality due to cardiovascular disease in both sexes was drawn during the period of the study according to age groups in the 2010 and their frequency distributions. The WinPepi software was used for data analyses. Results: Evaluation of the mortality profile in Iran (29 Provinces) over the Years 2006 to 2010 is shown that, during these years, the number of deaths from all causes in the country was 1,172,278, which 46.04 percent of them (539,679 cases) were due to cardiovascular disease. Also, according to the data on the mortality from cardiovascular disease, a decreasing trend was observed in the country during 2006 to 2008, while an increasing trend was observed the years 2009 to 2010. Highest number of deaths due to cardiovascular disease was reported in 2006, 115,985 cases, while least number was reported in 2008, 104,126 cases. Conclusion: Because the risk of death from cardiovascular disease increases with ageing, medical interventions for the prevention of cardiovascular disease risk factors in childhood and adolescence and, also, in-time treatment of the patients can be used for preventing from mortality resulted from these disease.